Cloud PR Wire

BioHarvest Sciences announces Health Canada has approved VINIA Sales in Canada

–News Direct– BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from Proactive to share news Health Canada has granted BioHarvest Sciences a Canadian product license through Health Canada's Natural and Non-Prescription Health Products Directorate. Sobel explained that this newly acquired license now authorizes the company to sell VINIA in Canada, a pivotal step in their…

Keep Reading
Cloud PR Wire

NexTech3D.ai ending year with strong results in four key business units

–News Direct– NextTech3D.ai CEO Evan Gappelberg joined Steve Darling from Proactive with a comprehensive corporate update, shedding light on the various business units under NextTech3D.ai and their impressive achievements. One noteworthy highlight is the company's collaboration with major clients like Amazon, Kohl's, and others, where NextTech3D.ai has been instrumental in building over 60,000 models. The…

Keep Reading
Cloud PR Wire

Culpeo Minerals announces company has increased land package at Fortuna Copper Project

–News Direct– Culpeo Minerals managing director Max Tuesley joined Steve Darling from Proactive to discuss the company's latest strategic move a significant acquisition of land on the eastern boundary of the Fortuna Project. Tuesley highlighted the vast scale of this new land package, encompassing a sprawling area spanning 2,250 hectares. What makes this acquisition particularly…

Keep Reading
Cloud PR Wire

HPQ Silicon announces successful silicon pour and validation in PUREVAP Gen 3 testing

–News Direct– HPQ Silicon CEO Bernard Tourillon joined Steve Darling from Proactive to share some significant developments that the company's partner, PyroGenesis, has made noteworthy improvements aimed at enhancing the fluidity of liquid silicon at the Gen3 QRR reactor's base. Furthermore, they have achieved a crucial milestone by successfully completing a silicon pour. Tourillon emphasized…

Keep Reading
Cloud PR Wire

Cardiol Therapeutics releases positive study results of subcutaneously administered cannabidiol

–News Direct– Cardiol Therapeutics CEO David Elsley joined Steve Darling from Proactive with news the company has unveiled highly promising study results from international research, which showcased the remarkable potential of subcutaneously administered cannabidiol, the active pharmaceutical ingredient found in Cardiol's groundbreaking CRD-38 subcutaneous formulation. In this study, it was revealed that the application of…

Keep Reading
Cloud PR Wire

Perimeter Medical Imaging AI shortlisted for grant funding under Biden Cancer Moonshot initiative

–News Direct– Perimeter Medical Imaging AI CEO Adrian Mendes joined Proactive's Stephen Gunnion with news that the company has been shortlisted in a grant funding process sponsored by the Advanced Research Projects Agency for Health (ARPA-H) as part of its Precision Surgical Interventions (PSI) program. Mendes explained that the initiative aims to provide groundbreaking tools…

Keep Reading